Carlsmed Inc CARL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
-
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
-
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
-
Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical
-
Carlsmed, Inc. Announces Chief Operating Officer Appointment
-
Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance
-
Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures
Trading Information
- Previous Close Price
- $13.95
- Day Range
- $13.41–14.30
- 52-Week Range
- $8.50–17.23
- Bid/Ask
- $11.50 / $15.40
- Shares Outstanding
- 27.30M
- Market Cap
- $366.13M
- Volume/Avg
- 73,230 / 112,109
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.25
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 127
- Website
- https://www.carlsmed.com
Valuation
|
Metric
|
CARL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.68 |
Price/Sales | 3.25 |
Price/Cash Flow | — |
Price/Earnings
CARL
Financial Strength
|
Metric
|
CARL
|
|---|---|
Quick Ratio | 8.31 |
Current Ratio | 8.84 |
Interest Coverage | −29.03 |
Quick Ratio
CARL
Profitability
|
Metric
|
CARL
|
|---|---|
Return on Assets (Normalized) | −25.92% |
Return on Equity (Normalized) | −48.14% |
Return on Invested Capital (Normalized) | −39.86% |
Return on Assets
CARL
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|%S$c^^> | LOCK|fL! | $50B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|wXQW | $13B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|?TRnT | $13B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|MX@y< | $12B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|>?# | $12B | |||
| M3 Inc
MTHRF
| — | LOCK|$!<S | $8B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|?j@$s | $8B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|fPqf | $8B | |||
| HealthEquity Inc
HQY
| — | LOCK|#FR# | $8B | |||
| Doximity Inc Class A
DOCS
| — | LOCK|p&^ | $6B |
United States